Darzalex (daratumumab) - J&J
dazukibart (PF-06823859) - Pfizer
Simulect (basiliximab) - Novartis
Actemra IV (tocilizumab) - Roche, JW Pharma, Chugai Pharmaceutical
Saphnelo (anifrolumab-fnia) - AstraZeneca
http://www.ncbi.nlm.nih.gov/pubmed/42712119
 
Eugene Krustev; Laurence Poirier-Blanchette; Na'ama Avitzur
 
Sep 10, 2026
 
Prev Next